Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Tasquinimod, an S100A9 Inhibitor, in Combination with Ixazomib, Lenalidomide, and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Dan T. Vogl, Yulia Nefedova, E. Paul Wileyto, Chau Nguyen, Cynthia Diaczynsky, Inna Strakovsky, Eva Bondesson, Helen Tuvesson, Erik Vahtola, Adam D. Cohen, Sandra Susanibar-Adaniya, Adam Waxman, Shivani Kapur, Alfred L. Garfall, Edward A. Stadtmauer

Blood (2024) 144 (Supplement 1): 7060.

https://doi.org/10.1182/blood-2024-204155

Published: 2024

Journal Articles

Tasquinimod Improves Erythropoiesis and Mitigates Bone Loss in Myelodysplastic Mice

Manja Wobus, Heike Weidner, Kristin Möbus, Anna-Lena Baumann, Ivonne Habermann, Tolga Danismaz, Ekaterina Balaian, Marie Törngren, Helena Eriksson, Eva Bondesson, Martina Rauner, Martin Bornhaeuser, Katja Sockel

Blood (2023) 142 (Supplement 1): 2798.

https://doi.org/10.1182/blood-2023-185642

Published: 2023

Journal Articles

Targeting S100A9 in the Inflammatory Myelodysplastic Hematopoietic Niche Reprograms the Functional Properties of CD271 + Mesenchymal Stromal Cells

Manja Wobus, Ekaterina Balaian, Triantafyllos Chavakis, Alexander Funk, Thomas Krüger, Uwe Platzbecker, Marie Törngren, Helena Eriksson, Eva Bondesson, Martin Bornhäuser, Katja Sockel

Blood (2022) 140 (Supplement 1): 4028–4029.

https://doi.org/10.1182/blood-2022-168866

Published: 2022

Journal Articles

A Phase 1 Study of Tasquinimod in Patients with Relapsed or Refractory Multiple Myeloma

Dan T. Vogl, MD, Yulia Nefedova, MD PhD, E. Paul Wileyto, PhD, Harjeet Sembhi, Inna Strakovsky, MPH, MRA, Chau Nguyen, Rimzim Taneja, Eva Bondesson, PhD, Helena Eriksson, PhD, Helen Tuvesson, PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-137482

Published: 2020